Pure Global

Rapid Drugs (Opiate ) Screening Test Kit - India CDSCO Medical Device Registration

Rapid Drugs (Opiate ) Screening Test Kit is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2022/000123_6b6340621f51000edda501efa25425e4_103ae7415b3f5e3a8174f3bc72fc208f. This device is marketed under the brand name including H5N1 and H1N1. The license holder is PARAMCARE LIFE SCIENCES PRIVATE LIMITED, and it is classified as Device Class Class C. The approving authority is Central Drug Standards Control Organization, Ahmedabad.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class C
Rapid Drugs (Opiate ) Screening Test Kit
UID: MFG/IVD/2022/000123_6b6340621f51000edda501efa25425e4_103ae7415b3f5e3a8174f3bc72fc208f

Brand Name

including H5N1 and H1N1

Device Class

Class C

Approving Authority

Central Drug Standards Control Organization, Ahmedabad

Product Information

The Rapid Drugs (Opiate (including H5N1 and H1N1)) Screening Test Kit is a rapid test that qualitatively detects the presence of Opiate (including H5N1 and H1N1) in human urine specimen at the cut off value of 300 ng/mL. The test utilizes a combination of monoclonal antibody and BSA conjugated Opiate (including H5N1 and H1N1) to detect Opiate (including H5N1 and H1N1) in human urine sample

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing